Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Shares Issued (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Shares Issued for 15 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.6 million through Dec 2025, up 1897.69% year-over-year, with the annual reading at $22.6 million for FY2025, 211.29% up from the prior year.
  • Shares Issued for Q4 2025 was $3.0 million at Plus Therapeutics, down from $18.7 million in the prior quarter.
  • The five-year high for Shares Issued was $18.7 million in Q3 2025, with the low at -$2.3 million in Q3 2023.
  • Average Shares Issued over 4 years is $3.5 million, with a median of $1.2 million recorded in 2023.
  • Peak annual rise in Shares Issued hit 4296.77% in 2023, while the deepest fall reached 170.56% in 2023.
  • Over 4 years, Shares Issued stood at $7.2 million in 2021, then tumbled by 91.64% to $600000.0 in 2022, then skyrocketed by 66.67% to $1.0 million in 2023, then soared by 200.3% to $3.0 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $3.0 million, $18.7 million, and $882000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.